日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

N-acetylcysteine overcomes NF1 loss-driven resistance to PI3Kα inhibition in breast cancer

N-乙酰半胱氨酸可克服乳腺癌中由NF1缺失引起的对PI3Kα抑制剂的耐药性

Priska Auf der Maur,Marcel P Trefny,Zora Baumann,Milica Vulin,Ana Luisa Correia,Maren Diepenbruck,Nicolas Kramer,Katrin Volkmann,Bogdan-Tiberius Preca,Pedro Ramos,Cedric Leroy,Tobias Eichlisberger,Katarzyna Buczak,Federica Zilli,Ryoko Okamoto,Roland Rad,Michael Rugaard Jensen,Christine Fritsch,Alfred Zippelius,Michael B Stadler,Mohamed Bentires-Alj

PI3K inhibition circumvents resistance to SHP2 blockade in metastatic triple-negative breast cancer

PI3K抑制剂可克服转移性三阴性乳腺癌对SHP2阻断的耐药性

Romain J Amante ,Charly Jehanno # ,Duvini De Silva # ,Marie-May Coissieux # ,Markus Ackerknecht # ,Vincent Romanet ,Atul Sethi ,Baptiste Hamelin ,Bogdan-Tiberius Preca ,Salvatore Piscuoglio ,Charlotte K Y Ng ,Morvarid Mohseni ,Mohamed Bentires-Alj

A high-throughput drug screen reveals means to differentiate triple-negative breast cancer

高通量药物筛选揭示了区分三阴性乳腺癌的方法

Milica Vulin ,Charly Jehanno ,Atul Sethi ,Ana Luísa Correia ,Milan M S Obradović ,Joana Pinto Couto ,Marie-May Coissieux ,Maren Diepenbruck ,Bogdan-Tiberius Preca ,Katrin Volkmann ,Priska Auf der Maur ,Alexander Schmidt ,Simone Münst ,Loïc Sauteur ,Michal Kloc ,Marta Palafox ,Adrian Britschgi ,Vincent Unterreiner ,Olaf Galuba ,Isabelle Claerr ,Sandra Lopez-Romero ,Giorgio G Galli ,Daniel Baeschlin ,Ryoko Okamoto ,Savas D Soysal ,Robert Mechera ,Walter P Weber ,Thomas Radimerski ,Mohamed Bentires-Alj

ADAM9 contributes to vascular invasion in pancreatic ductal adenocarcinoma

ADAM9 促进胰腺导管腺癌的血管侵袭

Victor O Oria, Paul Lopatta, Tatjana Schmitz, Bogdan-Tiberius Preca, Alexander Nyström, Catharina Conrad, Jörg W Bartsch, Birte Kulemann, Jens Hoeppner, Jochen Maurer, Peter Bronsert, Oliver Schilling

Interconnected feedback loops among ESRP1, HAS2, and CD44 regulate epithelial-mesenchymal plasticity in cancer

ESRP1、HAS2和CD44之间的相互反馈回路调节癌症的上皮间质可塑性

Mohit Kumar Jolly, Bogdan-Tiberius Preca, Satyendra C Tripathi, Dongya Jia, Jason T George, Samir M Hanash, Thomas Brabletz, Marc P Stemmler, Jochen Maurer, Herbert Levine

A novel ZEB1/HAS2 positive feedback loop promotes EMT in breast cancer

一种新型的 ZEB1/HAS2 正反馈回路促进乳腺癌的 EMT

Bogdan-Tiberius Preca, Karolina Bajdak, Kerstin Mock, Waltraut Lehmann, Vignesh Sundararajan, Peter Bronsert, Alexandra Matzge-Ogi, Véronique Orian-Rousseau, Simone Brabletz, Thomas Brabletz, Jochen Maurer, Marc P Stemmler

ERN1 and ALPK1 inhibit differentiation of bi-potential tumor-initiating cells in human breast cancer

ERN1 和 ALPK1 抑制人类乳腺癌双潜能肿瘤起始细胞的分化

Juliane Strietz, Stella S Stepputtis, Bogdan-Tiberius Preca, Corinne Vannier, Mihee M Kim, David J Castro, Qingyan Au, Melanie Boerries, Hauke Busch, Pedro Aza-Blanc, Susanne Heynen-Genel, Peter Bronsert, Bernhard Kuster, Elmar Stickeler, Thomas Brabletz, Robert G Oshima, Jochen Maurer

ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat

类 HDAC 抑制剂莫西替诺他可逆转癌细胞中与 ZEB1 相关的耐药性

Simone Meidhof, Simone Brabletz, Waltraut Lehmann, Bogdan-Tiberius Preca, Kerstin Mock, Manuel Ruh, Julia Schüler, Maria Berthold, Anika Weber, Ulrike Burk, Michael Lübbert, Martin Puhr, Zoran Culig, Ulrich Wellner, Tobias Keck, Peter Bronsert, Simon Küsters, Ulrich T Hopt, Marc P Stemmler, Thomas B

The EMT-activator ZEB1 induces bone metastasis associated genes including BMP-inhibitors

EMT 激活剂 ZEB1 诱导骨转移相关基因,包括 BMP 抑制剂

Kerstin Mock, Bogdan-Tiberius Preca, Tilman Brummer, Simone Brabletz, Marc P Stemmler, Thomas Brabletz